Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-06-12
2007-06-12
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S343000, C544S332000, C546S279100
Reexamination Certificate
active
11050663
ABSTRACT:
The present invention relates to novel dipeptidyl peptidase IV (DPP-IV) inhibitors their analogs, isomers, pharmaceutical compositions, therapeutic uses and methods of making the same.
REFERENCES:
patent: 5691356 (1997-11-01), Das et al.
patent: 5939560 (1999-08-01), Jenkins et al.
patent: 6011155 (2000-01-01), Villhauer
patent: 6172081 (2001-01-01), Damon
patent: 6380398 (2002-04-01), Kanstrup et al.
patent: 2004/0072892 (2004-04-01), Fukushima et al.
patent: 2004/0121964 (2004-06-01), Madar et al.
patent: 1354882 (2003-10-01), None
patent: 1 464 335 (2004-10-01), None
patent: WO-93/01167 (1993-01-01), None
patent: WO-93/17020 (1993-09-01), None
patent: WO-94/24093 (1994-10-01), None
patent: WO-97/40832 (1997-11-01), None
patent: WO98/19998 (1998-05-01), None
patent: WO-01/46199 (2001-06-01), None
patent: WO-01/96295 (2001-12-01), None
patent: WO-01/96346 (2001-12-01), None
patent: WO-03/013526 (2003-02-01), None
patent: WO-03/037327 (2003-05-01), None
patent: WO-03/084940 (2003-10-01), None
patent: WO2004/016587 (2004-02-01), None
patent: WO-2004-087680 (2004-10-01), None
patent: WO2005/023762 (2005-03-01), None
patent: WO-2005/033072 (2005-04-01), None
Madar et al., STN International, HCAPLUS Database, Columbus, OH, Accession No. 2004:1127082, Reg. No. 813433-88-4P (2007).
Varljen et al., “Clinical Relevance of the Serum Dipeptidyl Peptidase IV (DPP IV/CD26) Activity in Adult Patients with Crohn's Disease and Ulcerative Colitis,” Croatica Chemica Acta, 78(3), 427-432 (2005).
Mitani et al., “Dipeptidyl Peptidase IV Inhibition: Improves Impaired Glucose Tolerance in High-Fat Diet-Fed Rats: Study Using a Fischer 344 Rat Substrain Deficient in Its Enzyme Activity,” Jpn. J. Pharmacol., 88, 442-450 (2002).
Ashworth, et al.,Bioorganic&Medicinal Chem. Ltrs.vol. 6, No. 10 pp. 1163-1166, 1996;2-Cyanopyrrolidides as Potent, Stable Inhibitors of Dipeptidyl Peptidase IV.
Coutts et al.,J. Med. Chem.1996, 38, 2087-2094,Structure-Activity Relationships of Boronic Acid Inhibitors of Dipeptidyl Peptidase IV. 1. Variation of the P2Position of X88-boroPro Dipeptides.
Hughes et al.,Biochemistry1999, 38, 11597-11603, (1-[[[2-[(5-Cyanopyridin-2-yl)amino]ethyl]amino]acetyl]-2-cyano(S)-pyrrolidine) ,a Slow-Binding Inhibitor of Dipeptidyly Peptidase IV.
Villhauer et al.,J. Med. Chem.2003, 46 2774-2789, 1-[[(3-Hydrody-1-adamantyl) amino]acetyl]-2-cyano-(S)-pyrrolidine:A Potent, Selective, and Orally Bioavailable Dipeptidyl Peptidase IV Inhibitor with Antihyperglycemic Properties.
International Search Report for International Application No. PCT/US 03/29018 mailed Mar. 30, 2004.
Campbell, Jeffrey A., et al., “Chirospecific Syntheses of Precursors of Cyclopentane and Cyclopentane Carbocyclic Nucleosides by [3+3]-Coupling and Transannular Alkylation”, J. Org. Chem., 1995, vol. 60, pp. 4602-4616.
Mekrami, Mounia, et al., “Enzymatic Asymmetric Synthesis of Cis-4-cyclopentene- 1,3-dimethanol monoacetate”, Tetrahedron: Asymmetry, 1992, vol. 3, No. 3, pp. 431-436.
Fortt, Simon M., et al., “An Approach to a Carbocyclic Analogue of Cyclic Adenosine 5′-Diphosphate Ribose. The Synthesis and Biphosphorylation of N1-[(1S,3R)-3-(Hydroxymethyl)cyclopent-1-yl]inosine.”, Tetrahedron Letters, 1997, vol. 38, No. 30, pp. 5371-5374.
Grumann, Arne, et al., “The Synthesis of trans-Carbovir via the Ramberg-Backlund Reaction”, Tetrahedron Letters, 1995, vol. 36, No. 42, pp. 7767-7768.
Gopalan Balasubramanian
Lingam V. S. Prasada Rao
Shah Daisy Manish
Thomas Abraham
Darby & Darby
Freistein Andrew B.
Glenmark Pharmaceuticals Ltd.
Saeed Kamal A.
LandOfFree
Dipeptidyl peptidase IV inhibitors; processes for their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dipeptidyl peptidase IV inhibitors; processes for their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dipeptidyl peptidase IV inhibitors; processes for their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3816113